The Experts below are selected from a list of 3723 Experts worldwide ranked by ideXlab platform
Minghuei Cheng - One of the best experts on this subject based on the ideXlab platform.
-
Comparisons of Submental and Groin Vascularized Lymph Node Flaps Transfer for Breast Cancer-Related Lymphedema.
Plastic and reconstructive surgery. Global open, 2018Co-Authors: Chia-yu Lin, Marco Pappalardo, Minghuei ChengAbstract:Background The vascularized groin and submental lymph node (VGLN and VSLN) flaps are valuable options in the treatment of Lymphedema. This study was to compare outcomes between VGLN and VSLN transfers for Breast Cancer-Related Lymphedema. Methods Between January 2008 and December 2016, VGLN and VSLN transfers for upper limb Lymphedema were compared including flap characteristics, flap elevation time, complications, and limb circumference changes. Results All flaps survived. Similar vein (2.6 versus 3.2 mm; P = 0.3) and artery diameter (2.1 versus 2.8 mm; P = 0.3) and number of lymph nodes (3 versus 4; P = 0.4) were found between VGLN and VSLN groups, respectively. Circumferential reduction rate was higher in VSLN than VGLN (P = 0.04) group. Vascular complication rate with salvage rate was not statistically different between the 2 groups. Donor-site complication and total complication rates were statistically higher in VGLN than VSLN flaps (7.7% versus 0%, P = 0.004; 46.2% versus 23.3%, P = 0.002). At a mean 39.8 ± 22.4 months, the circumferential reduction rate was statistically higher in VSLN than in the VGLN group (55.5 ± 14.3% versus 48.4 ± 23.9%, P = 0.04). Both flaps were effectively decreased in the episodes of cellulitis. Conclusions Both VGLN and VSLN flaps are valuable surgical options in treating Breast Cancer-Related Lymphedema. However, the VSLN flap for Breast Cancer-Related Lymphedema is better in providing more significant improvements in limb circumference, a faster flap harvest time, decreased complication rates, and minimal donor-site iatrogenic Lymphedema.
-
outcomes of Lymphedema microsurgery for Breast cancer related Lymphedema with or without microvascular Breast reconstruction
Annals of Surgery, 2017Co-Authors: Holger Engel, Jungju Huang, Minghuei ChengAbstract:Objective:This study investigated the outcome of Lymphedema microsurgery with or without microsurgical Breast reconstruction for Breast Cancer-Related Lymphedema (BCRL).Background:Complete decongestive therapy, lymphovenous anastomosis, and vascularized lymph node flap transfer are the 3 major treat
Jane M. Armer - One of the best experts on this subject based on the ideXlab platform.
-
Breast Cancer-Related Lymphedema and quality of life: A qualitative analysis over years of survivorship.
Chronic illness, 2019Co-Authors: Allison B. Anbari, Ausanee Wanchai, Jane M. ArmerAbstract:ObjectivesThe study purpose was to examine perspectives of women with newly diagnosed Breast Cancer-Related Lymphedema (BCRL) regarding their quality of life over seven years.MethodData were collec...
-
Effects of weight-lifting or resistance exercise on Breast Cancer-Related Lymphedema: A systematic review
Elsevier, 2019Co-Authors: Ausanee Wanchai, Jane M. ArmerAbstract:The purpose of this systematic review was to identify the effects of weight-lifting or resistance exercise on Breast Cancer-Related Lymphedema. Published articles written in English were retrieved from electronic databases, including ScienceDirect, PubMed, Scopus, and CINAHL databases. Hand-searches for unpublished papers were also completed. Content analysis was used to examine articles that met the inclusion criteria. Among 525 searched papers, 15 papers met the inclusion criteria: 13 trials evaluated weight-lifting or resistance exercise alone and two trials evaluated weight-lifting or resistance exercise plus aerobic exercise. The results of the review showed that no arm volume change was observed for either exercise modality. In addition, six included studies showed that weight-lifting or resistance exercise did not cause Lymphedema or adverse events in patients at risk of Breast Cancer-Related Lymphedema. For patients with Breast Cancer-Related Lymphedema, six studies reported that change of swelling outcome measures were not significantly different between the weight-lifting or resistance exercise group and the control group. However, three included studies reported that volume of arm was significantly more reduced in the weight-lifting or resistance exercise group than those in the control group. The findings suggest that supervised resistance exercise may be safe, feasible, and beneficial in patients with Breast Cancer-Related Lymphedema or at risk for Breast Cancer-Related Lymphedema. However, the limitation of small sample size implies that further research is needed to confirm these findings. Keywords: Breast neoplasms, Lymphedema, Resistance training, Weight liftin
-
Effects of weight-lifting or resistance exercise on Breast Cancer-Related Lymphedema: A systematic review
International journal of nursing sciences, 2018Co-Authors: Ausanee Wanchai, Jane M. ArmerAbstract:The purpose of this systematic review was to identify the effects of weight-lifting or resistance exercise on Breast Cancer-Related Lymphedema. Published articles written in English were retrieved from electronic databases, including ScienceDirect, PubMed, Scopus, and CINAHL databases. Hand-searches for unpublished papers were also completed. Content analysis was used to examine articles that met the inclusion criteria. Among 525 searched papers, 15 papers met the inclusion criteria: 13 trials evaluated weight-lifting or resistance exercise alone and two trials evaluated weight-lifting or resistance exercise plus aerobic exercise. The results of the review showed that no arm volume change was observed for either exercise modality. In addition, six included studies showed that weight-lifting or resistance exercise did not cause Lymphedema or adverse events in patients at risk of Breast Cancer-Related Lymphedema. For patients with Breast Cancer-Related Lymphedema, six studies reported that change of swelling outcome measures were not significantly different between the weight-lifting or resistance exercise group and the control group. However, three included studies reported that volume of arm was significantly more reduced in the weight-lifting or resistance exercise group than those in the control group. The findings suggest that supervised resistance exercise may be safe, feasible, and beneficial in patients with Breast Cancer-Related Lymphedema or at risk for Breast Cancer-Related Lymphedema. However, the limitation of small sample size implies that further research is needed to confirm these findings.
-
Effect of Common Medications on Breast Cancer-Related Lymphedema
Rehabilitation Oncology, 2018Co-Authors: Emily Tesar, Jane M. ArmerAbstract:Background:It is estimated that 15% to 28% of Breast cancer survivors suffer from Breast cancer–related Lymphedema (BCRL). As the population of survivors grows, so does their risk for developing other chronic diseases such as cardiac disease, type II diabetes, chronic obstructive pulmonary disease,
-
Breast Cancer-Related Lymphedema: A literature review for clinical practice
International Journal of Nursing Sciences, 2016Co-Authors: Ausanee Wanchai, Jane M. Armer, Bob R. Stewart, Bonnie B. LasinskiAbstract:Abstract Lymphedema is the swelling of soft tissues as a result of the accumulation of protein-rich fluid in extracellular spaces. Secondary Lymphedema is precipitated by an event causing blockage or interruption of the lymphatic vessels. Secondary Lymphedema is a potential complication that may affect the quality of life of patients treated for Breast cancer. Life-long risk factors of post-Breast cancer Lymphedema are related to the extent of axillary node involvement, type of Breast surgery, and radiation therapy. These factors decrease lymphatic drainage and increase stasis of fluids in the areas of skin and subcutaneous tissues that drain to regional lymph nodes. Breast Cancer-Related Lymphedema can involve the arm and hand, as well as the Breast and trunk on the operative side. Clinical symptom assessment and circumferential measures are widely used to evaluate Lymphedema. Treatment of Lymphedema associated with Breast cancer can include combined modality approaches, compression therapy, therapeutic exercises, and pharmacotherapy.
Kwan Sik Seo - One of the best experts on this subject based on the ideXlab platform.
-
A comparison of the effectiveness of complex decongestive physiotherapy and stellate ganglion block with triamcinolone administration in Breast Cancer-Related Lymphedema patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015Co-Authors: Jeong Gil Kim, Soon Ook Bae, Kwan Sik SeoAbstract:Purpose This study aims to investigate the comparison of effectiveness between stellate ganglion block (SGB) and complex decongestive physiotherapy (CDT) in Breast Cancer-Related Lymphedema (BCRL) patients.
-
Quality of Life, Upper Extremity Function and the Effect of Lymphedema Treatment in Breast Cancer Related Lymphedema Patients
Annals of rehabilitation medicine, 2012Co-Authors: Ji Eung Park, Hye Jin Jang, Kwan Sik SeoAbstract:OBJECTIVE To evaluate quality of life (QOL), upper extremity function and the effect of Lymphedema treatment in patients with Breast cancer related Lymphedema. METHOD The basic data comprised medical records (detailing age, sex, dominant side, location of tumor, cancer stage, operation record, cancer treatment and limb circumferences) and questionnaires (Lymphedema duration, satisfaction, self-massage). Further to this, we measured upper extremity function and QOL, administered the DASH (Disabilities of Arm Shoulder and Hand outcome measure) and used the EORTC (European Organization for Research and Treatment of Cancer)-QLQ-C30 and the EORTC-QLQ-Br23. Results of these were calculated as main outcome variables. RESULTS The questionnaire responses and arm circumferences of 59 patients with Breast cancer related Lymphedema were analyzed. In the DASH questionnaire, it was found that the older the Lymphedema patient was, the lower their upper extremity function. On the EORTC-QLQ, patients with metastasis had significantly lower scores in physical functioning and role functioning. In terms of upper extremity circumference, there was a significant upper extremity size reduction after Lymphedema treatment. CONCLUSION There were several dissociations between some subscales of quality of life questionnaires and those of upper extremity functions. Upper extremity function was correlated with the age of Breast cancer patients and QOL was influenced by M-stage. Lymphedema treatment was found to be effective in reducing edema in patients with Breast cancer related Lymphedema.
Frank A. Vicini - One of the best experts on this subject based on the ideXlab platform.
-
Utilization of bioimpedance spectroscopy (BIS) to reduce rates of Breast cancer related Lymphedema (BCRL) in extremely high-risk patients.
Journal of Clinical Oncology, 2018Co-Authors: Sharon W. W. Chan, Frank A. Vicini, H May Lee, Polly S. Y. CheungAbstract:e22112Background: We evaluated the use of bioimpedance spectroscopy (BIS) as part of a structured surveillance program for the development of Breast Cancer-Related Lymphedema (BCRL) in very high ri...
-
Utilization of bioimpedance spectroscopy in the prevention of chronic Breast Cancer-Related Lymphedema
Breast cancer research and treatment, 2017Co-Authors: David I. Kaufman, Chirag Shah, Frank A. Vicini, Marisa RizziAbstract:Background This analysis was performed to assess the impact of early intervention following prospective surveillance using bioimpedance spectroscopy (BIS) to detect and manage Breast Cancer-Related Lymphedema (BCRL).
-
Reducing chronic Breast cancer related Lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy (BIS).
Journal of Clinical Oncology, 2017Co-Authors: Pat Whitworth, Chirag Shah, Frank A. Vicini, Andrea CooperAbstract:10117Background: Breast cancer related Lymphedema (BCRL) represents a major side effect that can significantly impact quality of life. Current guidelines support prospective surveillance to allow f...
-
Breast Cancer Related Lymphedema: A Review of Recent Developments
2013Co-Authors: Chirag Shah, Shahed N. Badiyan, Shariq Khwaja, Pawel Dyk, Douglas W. Arthur, Brian D. Lawenda, Steven E. Finkelstein, Frank A. ViciniAbstract:Breast Cancer Related Lymphedema: A Review of Recent Developments With improved methods of detection and advancing treatment paradigms, Breast cancer outcomes continue to improve. Along with this improved survivorship, an increased focus on long term sequelae of treatment must occur. Breast cancer related Lymphedema (BCRL) represents one of the most frequently recognized complications following Breast cancer treatment and has been found to be associated with the extent of locoregional therapy. With regards to incidence rates, several randomized trials have found that with utilization of less aggressive axillary staging (i.e., sentinel lymph node biopsies), that rates of BCRL are reduced compared with axillary lymph node dissections.
Ji Eung Park - One of the best experts on this subject based on the ideXlab platform.
-
Quality of Life, Upper Extremity Function and the Effect of Lymphedema Treatment in Breast Cancer Related Lymphedema Patients
Annals of rehabilitation medicine, 2012Co-Authors: Ji Eung Park, Hye Jin Jang, Kwan Sik SeoAbstract:OBJECTIVE To evaluate quality of life (QOL), upper extremity function and the effect of Lymphedema treatment in patients with Breast cancer related Lymphedema. METHOD The basic data comprised medical records (detailing age, sex, dominant side, location of tumor, cancer stage, operation record, cancer treatment and limb circumferences) and questionnaires (Lymphedema duration, satisfaction, self-massage). Further to this, we measured upper extremity function and QOL, administered the DASH (Disabilities of Arm Shoulder and Hand outcome measure) and used the EORTC (European Organization for Research and Treatment of Cancer)-QLQ-C30 and the EORTC-QLQ-Br23. Results of these were calculated as main outcome variables. RESULTS The questionnaire responses and arm circumferences of 59 patients with Breast cancer related Lymphedema were analyzed. In the DASH questionnaire, it was found that the older the Lymphedema patient was, the lower their upper extremity function. On the EORTC-QLQ, patients with metastasis had significantly lower scores in physical functioning and role functioning. In terms of upper extremity circumference, there was a significant upper extremity size reduction after Lymphedema treatment. CONCLUSION There were several dissociations between some subscales of quality of life questionnaires and those of upper extremity functions. Upper extremity function was correlated with the age of Breast cancer patients and QOL was influenced by M-stage. Lymphedema treatment was found to be effective in reducing edema in patients with Breast cancer related Lymphedema.